Related Experiment Video
Updated: Aug 29, 2025
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials
Daniela F Ward Grados1, Hamed Ahmadi1, Thomas S Griffith1,2
1Department of Urology, University of Minnesota, Minneapolis, MN, USA.
Immunological Investigations
|September 9, 2022
Summary
Immunotherapy, including Bacillus Calmette-Guerin (BCG) and checkpoint inhibitors like Pembrolizumab, is crucial for bladder cancer treatment. Research is optimizing these therapies for both early and advanced stages.
Area of Science:
- Urology
- Oncology
- Immunology
Background:
- Bacillus Calmette-Guerin (BCG) has been a standard immunotherapy for non-muscle invasive bladder cancer for nearly 50 years.
- Checkpoint inhibitor drugs (Pembrolizumab, Atezolizumab) show significant promise in treating bladder cancer.
Approach:
- This review summarizes the current landscape of bladder cancer immunotherapy.
- It highlights novel therapeutic strategies and ongoing clinical trials.
Key Points:
- Immunotherapy represents a cornerstone in bladder cancer management.
- Optimizing existing and exploring new immunotherapeutic approaches is critical.
- Current research focuses on both non-muscle invasive and advanced bladder cancer.
Conclusions:
- The field of bladder cancer immunotherapy is rapidly evolving.
- Novel approaches and ongoing trials are expanding treatment options.
- Further research is essential to improve patient outcomes in bladder cancer.
Related Concept Videos
01:27Tumor Immunotherapy
643
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
01:30Cancer Vaccines
494
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
494
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K